Diabetics use glucose monitors. Should non-diabetics use them too?
Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
Glucose monitors for diabetes have finally been funded – but there's a problem
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
The role of continuous glucose monitoring in holistic diabetes management
Continuous glucose monitoring (CGM) technologies have transformed diabetes management by providing real-time, accurate ...
AZoSensors on MSN2d
Monitoring Glucose with Sweat-Based Biosensors
This study presents a noninvasive biosensor that measures glucose levels through sweat, providing an alternative to ...
Armed robbery in Revesby2d
Glucose Monitors Funded, Workforce Shortage Looms
Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...
WISH-TV on MSN6d
How continuous glucose monitoring is changing health management
Discover how continuous glucose monitoring can revolutionize your health. Learn how to optimize your diet and exercise with ...
clinicaladvisor.com6d
Cases of Adverse Mental Health Outcomes Developing With Continuous Glucose Monitoring
The study author endorses preassessment and providing psychoeducation or combining CGM initiation with therapy, mindfulness, ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
Abbott Q3: Strong Growth In Medical Device And Pharma
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...